https://www.selleckchem.com/pr....oducts/Temsirolimus.
Results Baseline characteristics and functional outcome at 90 days did not differ between the bridging and direct MTE groups. Shorter MTE procedure and hospitalization time (p = 0.025 and p = 0.036, respectively) were observed in the direct MTE group. An IVT treatment subgroup analysis showed higher rates of symptomatic ICH (p less then 0.001) and longer intervals between imaging to MTE (p = 0.005) in the full r-tPA dose group. Conclusions In patients with an MCA stroke, direct MTE seems to be a safe and equally effective as bridgi
Curtir
Comentario
Compartilhar
